Loading chart…
PRE-MARKET
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates.
Vineet Laboratories Limited (VINEETLAB) is listed on the NSE in the Basic Materials sector, Chemicals industry. The VINEETLAB share price is ₹37.04 (+1.76% today), with a market capitalisation of ₹71Cr and a price-to-earnings (P/E) ratio of 15.2. MarketRipple tracks the VINEETLAB investment thesis, the ripple-chain impact of market events on Vineet Laboratories Limited, and the Basic Materials sector outlook.
Open
₹37.69
High
₹37.69
Low
₹35.87
Prev. Close
₹36.40
52W High
₹47.39
52W Low
₹27.96
Day range
₹35.87–₹37.69
52-week range
₹27.96–₹47.39
Volume
222K
P/E
15.2
ROE
2.4%
D/E
0.99
Margin
5.6%
Vineet Laboratories Limited (NSE: VINEETLAB) is currently trading at ₹37.04 (+1.76%).
Vineet Laboratories Limited's market capitalization is ₹71Cr.
Vineet Laboratories Limited's price-to-earnings (P/E) ratio is 15.2.
Vineet Laboratories Limited operates in the Basic Materials sector (Chemicals).